There are 296 Drug Discovery investors in the AngelBacked database, ranked below by portfolio size. The most active include Bryan Schreier, David Bonita and Houman Haghighi. Each profile lists portfolio companies, sector focus, check size, and contact details.
Executive Vice President, Head of Research and Development
Senior Associate, Business Development
Senior Associate, Business Development
Vice President, Sandbox Healthcare
Sign up to view contact details, LinkedIn profiles, and export investor data.
AngelBacked lists 296 angel investors and VCs who invest in Drug Discovery startups. The most active by portfolio size include Bryan Schreier, David Bonita, Houman Haghighi.
Ranked by number of portfolio companies, the most active Drug Discovery investors in the AngelBacked database are Bryan Schreier, David Bonita, Houman Haghighi. Each profile lists their portfolio, sector focus, and contact details.
Every Drug Discovery investor profile on AngelBacked includes a verified email address alongside their portfolio companies, sector focus, and firm. Paid plans unlock the contact details and CSV export.
Check sizes vary by stage: angel investors backing Drug Discovery startups typically write $25K–$100K, while Drug Discovery-focused VCs range from $500K to $5M+ for early-stage rounds. Filter the database by check size to match your raise.